Humacyte Ownership | Who Owns Humacyte?

Overview Forecast RevenueFinancials Chart Transcripts

Humacyte Ownership Summary

Humacyte is owned by 25.96% institutional investors, 16.36% insiders, and 57.68% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 7.17% of HUMA shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.74% of its assets in Humacyte shares.

HUMA Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Humacyte	25.96%	16.36%	57.68%
Sector	Healthcare Stocks	232.01%	10.74%	-142.75%
Industry	Biotech Stocks	381.47%	10.55%	-292.02%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock funding, inc. /de	11.35M	7.17%	$10.90M
Blackrock	7.14M	6.60%	$34.27M
Vanguard group	8.42M	5.32%	$8.09M
Geode capital management	3.72M	2.35%	$3.57M
Ubs group	2.98M	1.88%	$2.86M
Morgan stanley	2.51M	1.58%	$2.41M
State street	2.41M	1.55%	$4.19M
Woodline partners lp	2.00M	1.29%	$3.48M
Two sigma investments, lp	1.37M	0.88%	$2.38M
Millennium management	918.85K	0.77%	$4.64M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Lion point capital, lp	83.50K	0.83%	$145.29K
Imprint wealth	18.91K	0.11%	$32.90K
Caitong asset management	22.10K	0.06%	$21.22K
Wealth effects	153.07K	0.05%	$147.02K
Lji wealth management	308.50K	0.05%	$296.31K
Endowment wealth management	105.91K	0.04%	$96.85K
Aristides capital	162.90K	0.03%	$156.47K
Lasalle st. investment advisors	67.32K	0.02%	$117.00K
Clarus wealth advisors	39.97K	0.02%	$44.37K
Xtx topco	193.62K	0.02%	$336.90K

Top Buyers

Holder	Shares	% Assets	Change
Blackrock	7.14M	0.00%	2.35M
Blackrock funding, inc. /de	11.35M	0.00%	1.44M
Bnp paribas arbitrage, snc	1.10M	0.00%	1.01M
Ubs group	2.98M	0.00%	976.27K
Vanguard group	8.42M	0.00%	896.92K

Top Sellers

Holder	Shares	% Assets	Change
Heights capital management	-	-	-4.03M
Ra capital management	-	-	-3.31M
Aigh capital management	-	-	-2.16M
Toronto dominion bank	-	-	-2.13M
Monashee investment management	-	-	-2.00M

New Positions

Holder	Shares	% Assets	Change	Value
Aristides capital	162.90K	0.03%	162.90K	$156.47K
Integrated advisors network	86.78K	0.01%	86.78K	$151.00K
Kovack advisors	72.60K	-	72.60K	$6.00
Fisher asset management	49.40K	-	49.40K	$47.45K
Creative planning	44.01K	0.00%	44.01K	$76.58K

Sold Out

Holder	Change
Clearstead advisors	-7.00
Org partners	-10.00
Principal securities	-15.00
Transce3nd	-16.00
Gen-wealth partners	-85.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2025	100	-32.89%	41,097,732	-10.40%	25	2.98%	52	-10.34%	19	-57.78%
Sep 30, 2025	91	-41.67%	30,080,405	-43.82%	19	1.63%	36	-64.36%	27	12.50%
Jun 30, 2025	163	-6.86%	56,940,940	-6.40%	36	1.71%	104	8.33%	26	-29.73%
Mar 31, 2025	176	2.92%	61,024,544	45.00%	46	3.74%	97	-	37	-7.50%
Dec 31, 2024	87	-42.38%	22,175,982	-38.04%	18	2.07%	52	-41.57%	18	-30.77%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	5.30M	2.74%	1.16M
iShares Russell 2000 ETF	3.76M	1.95%	3.39M
SPDR® S&P Biotech ETF	2.26M	1.43%	5.04K
Vanguard Institutional Extnd Mkt Idx Tr	1.70M	0.88%	-
Fidelity Small Cap Index	1.30M	0.67%	-1.54K
Nuveen Quant Small Cap Equity R6	728.27K	0.61%	-
iShares Biotechnology ETF	1.17M	0.61%	550.42K
iShares Russell 2000 Value ETF	992.54K	0.51%	992.54K
State St Russell Sm/Mid Cp® Indx SL Cl I	957.62K	0.50%	-
MEDICAL BioHealth EUR Acc	718.45K	0.45%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Aug 18, 2025	Dougan Brady W	-	Sell	$1.01M
Aug 20, 2025	Dougan Brady W	-	Sell	$934.86K
Aug 19, 2025	Dougan Brady W	-	Sell	$1.79M
Aug 19, 2025	Niklason Laura E	President, CEO and Director	Sell	$1.79M
Aug 18, 2025	Niklason Laura E	President, CEO and Director	Sell	$1.01M

Insider Transactions Trends

Date	Buy	Sell
2025 Q4	-	-
2025 Q3	-	6
2025 Q2	6	-
2025 Q1	-	-
2024 Q4	3	6

HUMA Ownership FAQ

Who Owns Humacyte?

Humacyte shareholders are primarily institutional investors at 25.96%, followed by 16.36% insiders and 57.68% retail investors. The average institutional ownership in Humacyte's industry, Biotech Stocks , is 381.47%, which Humacyte falls below.

Who owns the most shares of Humacyte?

Humacyte’s largest shareholders are Blackrock funding, inc. /de (11.35M shares, 7.17%), Blackrock (7.14M shares, 6.60%), and Vanguard group (8.42M shares, 5.32%). Together, they hold 19.08% of Humacyte’s total shares outstanding.

Does Blackrock own Humacyte?

Yes, BlackRock owns 6.60% of Humacyte, totaling 7.14M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 34.27M$. In the last quarter, BlackRock increased its holdings by 2.35M shares, a 49.10% change.

Who is Humacyte’s biggest shareholder by percentage of total assets invested?

Lion point capital, lp is Humacyte’s biggest shareholder by percentage of total assets invested, with 0.83% of its assets in 83.5K Humacyte shares, valued at 145.29K$.

Who is the top mutual fund holder of Humacyte shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Humacyte shares, with 2.74% of its total shares outstanding invested in 5.3M Humacyte shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools